The estimated Net Worth of Alexander D Cross is at least $9.16 Milione dollars as of 15 May 2013. Alexander Cross owns over 500 units of Ligand Pharmaceuticals stock worth over $9,161,196 and over the last 21 years Alexander sold LGND stock worth over $0.
Alexander has made over 1 trades of the Ligand Pharmaceuticals stock since 2013, according to the Form 4 filled with the SEC. Most recently Alexander bought 500 units of LGND stock worth $2,745 on 15 May 2013.
The largest trade Alexander's ever made was buying 500 units of Ligand Pharmaceuticals stock on 15 May 2013 worth over $2,745. On average, Alexander trades about 42 units every 0 days since 2003. As of 15 May 2013 Alexander still owns at least 88,866 units of Ligand Pharmaceuticals stock.
You can see the complete history of Alexander Cross stock trades at the bottom of the page.
Alexander's mailing address filed with the SEC is 4105 E. MADISON STREET, SUITE 320, SEATTLE, WA, 98112.
Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over $205,340,014 worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth $27,601,439 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... e Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of $2,239,733. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth $50,090.
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: